Comparison between Hamps Bio IPO and NACDAC Infrastructure IPO.
Hamps Bio IPO is a SME Bookbuilding IPO proposed to list at BSE SME while NACDAC Infrastructure IPO is a SME Bookbuilding proposed to list at BSE SME.
| Hamps Bio IPO | NACDAC Infrastructure IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Marwadi Chandarana Intermediaries Brokers Pvt.Ltd. | GYR Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Pure Broking Pvt.Ltd. | Giriraj Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Hamps Bio IPO is up to ₹5.91 Cr whereas the issue size of the NACDAC Infrastructure IPO is up to ₹9.24 Cr. The final issue price of Hamps Bio IPO is ₹51.00 per share and of NACDAC Infrastructure IPO is ₹35.00 per share.
| Hamps Bio IPO | NACDAC Infrastructure IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹33.00 per share | |
| Issue Price (Upper) | ₹35.00 per share | |
| Issue Price (Final) | ₹51.00 per share | ₹35.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 4000 shares |
| Fresh Issue Size | 11,58,000 shares | 26,40,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.91 Cr | up to ₹9.24 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 11,58,000 shares | 26,40,000 shares |
| Issue Size Total (Amount) | up to ₹5.91 Cr | up to ₹9.24 Cr |
Hamps Bio IPO opens on Dec 13, 2024, while NACDAC Infrastructure IPO opens on Dec 17, 2024. The closing date of Hamps Bio IPO and NACDAC Infrastructure IPO is Dec 17, 2024, and Dec 19, 2024, respectively.
| Hamps Bio IPO | NACDAC Infrastructure IPO | |
|---|---|---|
| Anchor Bid Date | Dec 16, 2024 | |
| Issue Open | Dec 13, 2024 | Dec 17, 2024 |
| Issue Close | Dec 17, 2024 | Dec 19, 2024 |
| Basis Of Allotment (Tentative) | Dec 18, 2024 | Dec 20, 2024 |
| Initiation of Refunds (Tentative) | Dec 19, 2024 | Dec 23, 2024 |
| Credit of Share (Tentative) | Dec 19, 2024 | Dec 23, 2024 |
| Listing date (Tentative) | Dec 20, 2024 | Dec 24, 2024 |
| Anchor Lockin End date 1 | Jan 19, 2025 | |
| Anchor Lockin End date 2 | Mar 20, 2025 |
Hamps Bio IPO P/E ratio is 31.94, as compared to NACDAC Infrastructure IPO P/E ratio of 47.78.
| Hamps Bio IPO | NACDAC Infrastructure IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 95.9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 71.99 | 69.84 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 31.94 | 47.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹22.22 Cr. | ₹36.84 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 21.14 | 35.57 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 18.31 | 25.88 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.31 | 0.54 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹1.60 | ₹0.73 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 14.84 | 26.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Hamps Bio IPO Retail Individual Investors (RII) are offered 5,80,000 shares while in NACDAC Infrastructure IPO retail investors are offered 5,80,000 shares. Qualified Institutional Buyers (QIB) are offered in Hamps Bio IPO and 5,20,000 shares in NACDAC Infrastructure IPO.
| Hamps Bio IPO | NACDAC Infrastructure IPO | |
|---|---|---|
| Anchor Investor Reservation | 7,80,000 shares | |
| Market Maker Reservation | 62,000 shares | 2,20,000 shares |
| QIB | 5,20,000 shares | |
| NII | 5,78,000 shares | 4,00,000 shares |
| RII | 5,80,000 shares | 9,40,000 shares |
| Employee | ||
| Others | ||
| Total | 11,58,000 shares | 26,40,000 shares |
Hamps Bio IPO subscribed 1,050.15x in total, whereas NACDAC Infrastructure IPO subscribed 1,556.88x.
| Hamps Bio IPO | NACDAC Infrastructure IPO | |
|---|---|---|
| QIB (times) | 236.39x | |
| NII (times) | 759.58x | 4,084.46x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1,339.73x | 2,503.66x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1,050.15x | 1,556.88x |
